1 |
Familial Cerebral Small Vessel Diseases of unknown etiology : a high throughput approach towards a better understanding of pathophysiological mechanisms / Maladies des petites artères cérébrales d'étiologie inconnue : une approche haut-débit pour une meilleure compréhension des mécanismes physiopathologiquesVerdura, Edgard 26 September 2016 (has links)
Les maladies des petites artères cérébrales sont un groupe hétérogène de maladies qui affectent les petites artères, artérioles, veines et/ou capillaires du cerveau. La plupart des patients sont des cas sporadiques, mais plusieurs formes héréditaires ont été identifiées.Toutefois, 15 % seulement des patients atteints d’une cSVD familiale sont porteurs d’une mutation dans l’un de ces gènes, suggérant l’implication d’autres gènes. Dans cette thèse, nous avons montré que des mutations hétérozygotes du gène HTRA1 étaient responsables d’environ 5 % des cSVD familiales. L’analyse fonctionnelle de ces mutations a montré un effet perte de fonction. L’âge de début chez les sujets hétérozygotes était beaucoup plus tardif que chez les patients CARASIL, où les deux allèles d’HTRA1 sont mutés. Ensuite, nous avons identifié 2 familles (incluant la famille rapportée sous l’acronyme PADMAL / Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy) portant deux mutations distinctes dans un site d’accrochage du microRNA miR-29, dans la partie 3’UTR du gène COL4A1.Quatre autres patients index porteurs du même type de mutations ont été identifiés dans notre cohorte de cas cSVD. L’analyse fonctionnelle de ces mutations a mis en évidence une up-régulation de l’expression du gène COL4A1. Le phénotype observé était très stéréotypé, caractérisé par la survenue d’infarctus pontiques dans la 3ème décade. L’identification des bases moléculaires de ces deux nouvelles formes de cSVD héréditaire a des applications diagnostiques immédiates. Elle renforce par ailleurs l’hypothèse du rôle essentiel d’une altération du matrisome dans les mécanismes physiopathologiques des cSVD / Cerebral small vessel diseases (cSVD) are a heterogeneous group of disorders affecting small arteries, arterioles, veins, and/or capillaries of the brain. In most cases cSVD are sporadic, but several hereditary monogenic forms have been identified. Nevertheless, only 15% of familial cSVD patients sent for genetic screening are carriers of mutations in one of these genes, suggesting the implication of other genes. In this thesis work, we showed that heterozygous mutations in HTRA1 are found in 5% of familial cSVD cases. Functional analysis of these mutations showed that most of them behave as loss-of-function mutations. Disease onset was much later (>25 years) than in CARASIL patients, in which both2 HTRA1 alleles are mutated. Afterwards, we identified 2 informative families (including the original family reported to be affected by PADMAL / Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy) harboring two different mutations in the binding site of miR-29 microRNA within the 3’UTR of COL4A1 gene. Four other index patients carrying the same type of mutations were identified in our patient cohort. Functional analysis of these mutations showed an up-regulation of COL4A1 gene expression. The observed phenotype was highly stereotyped in all patients, characterized by pontine infarcts appearing in the 3rd decade. Identification of the molecular defects underlying these two novel hereditary cSVD forms provides tools to improve the molecular diagnosis of cSVD. Besides, it reinforces the hypothesis of an essential role of matrisome alteration in cSVD pathophysiological mechanisms
|
2 |
Genetic associations with sporadic cerebral small vessel diseaseRannikmäe, Kristiina January 2017 (has links)
Background: Cerebral small vessel disease (SVD) causes substantial cognitive, psychiatric and physical disabilities. Despite its common nature, SVD pathogenesis and molecular mechanisms remain poorly understood, and prevention and treatment are probably suboptimal. Identifying the genetic determinants of SVD will improve understanding and may help identify novel treatment targets. The aim of this thesis is to better understand genetic associations with SVD through investigating its pathological, radiological and clinical phenotypes. Methods: To unravel the genetic associations with SVD, I used three complementary approaches. First, I performed a systematic review looking at existing intracerebral haemorrhage (ICH) classification systems and their reliability, to help inform future studies of ICH genetics. Second, I performed a series of systematic reviews and meta-analyses, investigating associations between genetic polymorphisms and histopathologically confirmed cerebral amyloid angiopathy (CAA). Third, I performed meta-analyses of existing genome-wide datasets to determine associations of >1000 common single nucleotide polymorphisms (SNP) in the COL4A1/COL4A2 genomic region with clinico-radiological SVD phenotypes: ICH and its subtypes, ischaemic stroke and its subtypes, and white matter hyperintensities. Results: The reliability of existing ICH classification systems appeared excellent in eight studies conducted in specialist centres with experienced raters, although these existing systems have several limitations. In my systematic evaluation of CAA genetics, meta-analyses of 24 studies including 3520 participants showed robust evidence for a dose-dependent association between APOE ɛ4 and histopathological CAA. There was, however, no convincing association between APOE ɛ2 and presence of CAA in a meta-analysis of 11 studies including 1640 participants. Meta-analyses of five studies including 497 participants showed, contrary to an existing popular hypothesis, that while APOE 4 may increase the risk of developing severe CAA vasculopathy, there is no clear evidence to support a role of ɛ2. There were few data about the role of APOE in hereditary CAA, but in the three studies that had looked at this, there was no evidence for an association between APOE ɛ4 and CAA severity. There were too few studies and participants to draw firm conclusions about the effect of non-APOE ε2/ε3/ε4 genetic polymorphisms on CAA, but there were positive associations with TGF-β1, TOMM40 and CR1 genes in four studies. Finally, in my meta-analyses of the COL4A1/COL4A2 genomic region, three intronic SNPs in COL4A2 were associated with SVD phenotypes: significantly with deep ICH, and suggestively with lacunar ischaemic stroke and WMH. Conclusions: I have shown that while existing ICH classification systems appear to have very good reliability, further research is needed to determine their performance in different settings. For large population-based prospective studies of ICH genetics, anatomical systems are likely to be more feasible, scalable and appropriate, although they have limitations and will need to be further developed. Using systematic reviews and meta-analyses, I have confirmed a dose-related association between APOE ɛ4 and histopathological CAA, but also demonstrated that, despite popular acceptance, there is insufficient data to draw firm conclusions about the association with APOE ɛ2. I found some positive associations with CAA in other genes, which merit replication in further larger studies, and showed that there is currently insufficient data about the role of APOE in hereditary CAA. Finally, I identified a novel association between a locus in a known hereditary SVD gene – COL4A2 – and sporadic SVD. This highlights a new and successful approach for selecting candidate genes and can be expanded in future studies to include other known hereditary SVD genes.
|
3 |
Identifying a Biomarker for Systemic Sclerosis Using Existing Genomic DataDutta, Joyeeta January 2021 (has links)
No description available.
|
4 |
Investigating the Role of Shroom3 in Collagen Regulation and Development of the Corneal StromaLappin, Cory James 14 August 2018 (has links)
No description available.
|
Page generated in 0.0294 seconds